Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -7.62 Million ILS | 0.0% |
| 2022 | - ILS | -100.0% |
| 2021 | 3.73 Million ILS | -15.89% |
| 2020 | 4.43 Million ILS | -20.39% |
| 2019 | 5.57 Million ILS | -11.61% |
| 2018 | 6.3 Million ILS | -3.55% |
| 2017 | 6.53 Million ILS | 101.32% |
| 2016 | 3.24 Million ILS | -51.46% |
| 2015 | 6.69 Million ILS | -6.42% |
| 2014 | 7.15 Million ILS | 372.88% |
| 2013 | 1.51 Million ILS | -61.7% |
| 2012 | 3.94 Million ILS | 0.0% |
| 2011 | - ILS | 0.0% |
| 2010 | - ILS | 0.0% |
| 2009 | - ILS | 0.0% |
| 2008 | - ILS | 0.0% |
| 2007 | - ILS | 0.0% |
| 2006 | - ILS | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | -7.62 Million ILS | 0.0% |
| 2023 FY | -7.62 Million ILS | 0.0% |
| 2023 Q2 | - ILS | 0.0% |
| 2023 Q4 | -7.62 Million ILS | 0.0% |
| 2023 Q1 | - ILS | 0.0% |
| 2022 Q4 | - ILS | 0.0% |
| 2022 Q1 | 6.09 Million ILS | 63.33% |
| 2022 FY | - ILS | -100.0% |
| 2022 Q2 | 6.97 Million ILS | 14.32% |
| 2022 Q3 | - ILS | -100.0% |
| 2021 FY | 3.73 Million ILS | -15.89% |
| 2021 Q2 | 4.55 Million ILS | -7.04% |
| 2021 Q3 | 4.04 Million ILS | -11.24% |
| 2021 Q4 | 3.73 Million ILS | -7.69% |
| 2021 Q1 | 4.9 Million ILS | 10.43% |
| 2020 Q4 | 4.43 Million ILS | -28.53% |
| 2020 FY | 4.43 Million ILS | -20.39% |
| 2020 Q1 | 7.14 Million ILS | 28.16% |
| 2020 Q2 | 6.7 Million ILS | -6.2% |
| 2020 Q3 | 6.21 Million ILS | -7.34% |
| 2019 Q3 | 4.94 Million ILS | -9.7% |
| 2019 FY | 5.57 Million ILS | -11.61% |
| 2019 Q4 | 5.57 Million ILS | 12.79% |
| 2019 Q1 | 5.34 Million ILS | -15.21% |
| 2019 Q2 | 5.47 Million ILS | 2.36% |
| 2018 FY | 6.3 Million ILS | -3.55% |
| 2018 Q4 | 6.3 Million ILS | -0.17% |
| 2018 Q3 | 6.31 Million ILS | -7.47% |
| 2018 Q2 | 6.82 Million ILS | -3.82% |
| 2018 Q1 | 7.09 Million ILS | 8.56% |
| 2017 Q1 | 3.59 Million ILS | 10.81% |
| 2017 Q4 | 6.53 Million ILS | 14.64% |
| 2017 Q3 | 5.7 Million ILS | 45.21% |
| 2017 FY | 6.53 Million ILS | 101.32% |
| 2017 Q2 | 3.92 Million ILS | 9.14% |
| 2016 Q3 | 3.99 Million ILS | -10.49% |
| 2016 FY | 3.24 Million ILS | -51.46% |
| 2016 Q2 | 4.46 Million ILS | -22.76% |
| 2016 Q4 | 3.24 Million ILS | -18.68% |
| 2016 Q1 | 5.77 Million ILS | -13.66% |
| 2015 Q1 | 7.94 Million ILS | 11.15% |
| 2015 FY | 6.69 Million ILS | -6.42% |
| 2015 Q4 | 6.69 Million ILS | 4.03% |
| 2015 Q3 | 6.43 Million ILS | -3.77% |
| 2015 Q2 | 6.68 Million ILS | -15.89% |
| 2014 Q2 | 6.02 Million ILS | 38.99% |
| 2014 FY | 7.15 Million ILS | 372.88% |
| 2014 Q1 | 4.33 Million ILS | 186.51% |
| 2014 Q4 | 7.15 Million ILS | 0.72% |
| 2014 Q3 | 7.09 Million ILS | 17.9% |
| 2013 Q1 | 3.27 Million ILS | -17.05% |
| 2013 Q2 | 2.52 Million ILS | -22.84% |
| 2013 Q3 | 774 Thousand ILS | -69.37% |
| 2013 FY | 1.51 Million ILS | -61.7% |
| 2013 Q4 | 1.51 Million ILS | 95.35% |
| 2012 Q4 | 3.94 Million ILS | 0.0% |
| 2012 FY | 3.94 Million ILS | 0.0% |
| 2011 FY | - ILS | 0.0% |
| 2010 FY | - ILS | 0.0% |
| 2009 FY | - ILS | 0.0% |
| 2008 FY | - ILS | 0.0% |
| 2007 FY | - ILS | 0.0% |
| 2006 FY | - ILS | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Matricelf Ltd | - ILA | Infinity% |